Cargando…
Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria
Congenital erythropoietic porphyria (CEP), also known as Günther’s disease, results from a deficient activity in the fourth enzyme, uroporphyrinogen III synthase (UROIIIS), of the heme pathway. Ciclopirox (CPX) is an off-label drug, topically prescribed as an antifungal. It has been recently shown t...
Autores principales: | Bernardo-Seisdedos, Ganeko, Charco, Jorge M., SanJuan, Itxaso, García-Martínez, Sandra, Urquiza, Pedro, Eraña, Hasier, Castilla, Joaquín, Millet, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230281/ https://www.ncbi.nlm.nih.gov/pubmed/34071291 http://dx.doi.org/10.3390/jpm11060485 |
Ejemplares similares
-
Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy
por: Blouin, Jean-Marc, et al.
Publicado: (2021) -
Erythrodontia in congenital erythropoietic porphyria
por: Bhavasar, Rashmi, et al.
Publicado: (2011) -
Congenital Erythropoietic Porphyria with Undescended Testis
por: Arora, Sandeep, et al.
Publicado: (2016) -
An Atypical Case of Congenital Erythropoietic Porphyria
por: Sudrié-Arnaud, Bénédicte, et al.
Publicado: (2021) -
Hypertrichosis and erythrodontia in congenital erythropoietic porphyria
por: Enciso, Leonardo
Publicado: (2021)